FundamentalVR Secures $20 Million Series B Growth Investment

FundamentalVR secures Series B growth investments to disrupt the medical simulation market – expected to be worth $4.2 billion by 2025. BOSTON – August 11, 2022 – FundamentalVR has raised an additional $20 million to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery. The transaction was led by EQT Life Sciences investing from the LSP Health Economics Fund 2, and joined by prior investors Downing Ventures, Tern Plc and Sana Kliniken. The new investments follow a Series A round in October 2019 and bring the company's total funding to over $30 million. FundamentalVR is the world's first scalable medical simulation platform to combine virtual reality and haptics through data, artificial intelligence, and multimodal learning.